DevoManc:
Accessing England’s only fully integrated NHS testbed
Colin Callow
Welcome
#DevoManc
3
DevoManc
Health Innovation
Manchester
Click to edit Master title
Health Innovation Manchester
Introduction to an Academic Health
Science System (AHSS)
Discover
Deliver
Deploy
Click to edit Master title
Vision and
Purpose
Discover
Deliver
Deploy
Click to edit Master title
The rising costs of health and social care and slow introduction of innovative solutions are a major
frustration to policy-makers and care providers
Patien Outcome across Greater Manchester are currently below national averages against a range of disease and
20%
Increase in over 65s population
between 2011 and 2021
30%
Increase in over 85s population
between 2011 and 2021
£2b
Funding deficit to the health economy
by 2021 if no action is taken
Fragmented and
slow decision-
making
Structures which do
not assist
collaboration and
co-ordination
Lengthy and
uncertain routes to
adoption
Excellent initiatives
in one locality are
not shared across
the system
Industry find multiplicity
of organisations/
initiatives confusing and
add to risk
The obstacles preventing rapid implementation
of innovations nationwide:
mortality figures and over the next five years, faces significant public health challenges
Click to edit Master title
Discover
Deliver
Deploy
Our vision is to be a
recognised
international leader in
accelerating innovation
that transforms
citizens’ health and
wellbeing ”
“
Click to edit Master title
We have established an ‘academic health science system’ that leverages the city region’s entire
spectrum of exceptional clinical, academic and public assets, alongside industry innovators
This syst m approach with shared focus and priorities, we are uniquely placed to shape & drive accelerated
2.8
million
citizens
The unique
offering of
Greater
Manchester
“
”
discovery, development & delivery of innovative digital, medical & health innovations
Click to edit Master title
Health Innovation Manchester brings together academic research and clinical excellence with
industry innovators, creating shorter and more certain pathways to enable adoption at scale
Health Innovation Manchester covers every stage of the translational pathway from discovery
Health Innovation
Manchester
is building upon
the strengths
and synergies of
both the AHSN
& AHSC
“
”
science through to commissioning and real world evaluation
Click to edit Master title
LOCAL
REGIONAL
NATIONAL
Health Innovation Manchester will enhance Greater Manchester’s position, showcasing
our city-region’s capabilities by aligning local, regional and national initiatives and strategies
Our strategic priorities align with and support not only the Greater Manchester-wide Digital Strategy but also the
Accelerating the
discovery,
development and
deployment of
innovation that
improves our
population’s health
and wellbeing
INTERNATIONAL
Contributing to
national and
international health
and life science policy
Positioning Greater
Manchester as an
internationally
renowned location for
life science, med-tech
and digital healthcare
research and
innovation
NATIONAL
national Accelerated Access Review and the Life Sciences Industrial Strategy, highlighting GM as an exemplar site
Click to edit Master title
The Innovation
Pathway
Discover
Deliver
Deploy
Click to edit Master title
Being at the heart of this unique and cohesive system ensures we have an in depth understanding
and clear view of the needs of citizens, patients, providers and commissioners.
Three major opportunities to highlight where system-wide innovation keeps people well, reduces pressure on health
• Driven by exciting advances
in basic research,
particularly in genomics,
digital technologies.
• The development of health
data analytics, using
integrated big data sets.
• Using exceptional insight
into entire citizen-level
health pathways, and the
ability to evaluate
treatments and care
pathways.
The future of healthcare and
medicine will be
• A streamlined and
accelerated decision-
making structures to aid
industry in navigating
disjointed systems.
• We have signed an MOU
with the Association of
British Pharmaceutical
Industries (ABPI) and are
working closely with them
to bring forward a pipeline
of innovations for rapid
adoption.
A new approach to working
with industry
• Will enable us to tackle the
perverse incentives in
existing health and care
funding which inhibit
investment.
• Evaluation of costs and
benefits of innovations
across the whole care
pathway, outside of
individual institutional
boundaries.
• Develop funding models
which incentivise providers
to invest in innovation.
New business models
and care providers, supports economic growth, and improves health outcomes for citizens and patients.
Click to edit Master title
The Innovation Pathway: providing structure, organisation and a systematic
approach to translation and adoption through the health and social care system
Adopti n and spread will be delivered through the Joint Commissioning and Provider Federation Boards,
Active horizon scanning of
innovations, targeted calls
to industry and industry
engagement to identify
prioritised innovations
Achieving the greatest and fastest
possible improvement to the
health and wellbeing of the 2.8
million people living in our region
and beyond.
Assessment against shared priorities for innovation with agreed criteria for
evaluating and adopting proposals.
nt of the feaibility and valu o the pr posal to the relevant pars of the health and
care system.
Clear and assured route f om ilot to adoptio acr ss all relvant providers, benefiting from
our extensive experience in delivering service change.
dopted ideas valuat d both quan itatively ad qualitatively to m asure benefits ag inst
xpecta ions.
c llective memoy of lessons e ned through the innovation pathway. Conv rting lessns
learnt int evolving practice t en ure enduring improvements.
stakeholder engagement, project management, economics and evaluation support
Click to edit Master title
Our exemplar projects will balance clinical need with innovation opportunity and support the work of
population health and social care professionals, and the needs of primary and secondary care providers
Exemplar projec s will be selected for their significant impact not only in improved patient outcomes but also for
Medical Technologies &
Diagnostics
Ehealth & Informatics
Service Delivery &
Improvement
Medicines
Informatics & Analytics
Precision Medicine
Clinical Research
Excellence
Primary Care
Secondary Care
Mental Health
Social Care
Population Health
their potential cost reduction to the health & social care system leading to positive impact in local economic activity
Click to edit Master title
Discover
Deliver
Deploy
Accessing the NHS
Accessing the NHS
Keith Chantler
• Single Hospital Service
• Assured Access
• www.intohealth.org
• Business – how to engagement better with
health & care Systems
Topics
Business Engagement With Health & Care Systems
Must Do
• Safe
• Effective (clinical & economic)
evidence)
•
(Increasingly) acceptable to
patients
• Affordable (Cost effective)
Important
• Clinical advantage
•
Implementable
•
Ideally transformational
• Compelling business case
We need innovations that help us to
improve the care and delivery within
and out of hospitals
Helping people to stay well longer is
critical
Helping to manage at a distance is
increasingly important – Manchester
is piloting Internet of Things
People matter – ask them what they
want to better manage their
particular circumstances
Market pull -v- Technology push
Panel session
Jon Rouse
Chief Officer
Greater Manchester Health and Social
Care Partnership
Rowena Burns
Executive Chair
Health Innovation Manchester
Keith Chantler
Director of Innovation
Central Manchester University
Foundation Trust
23
Thank you
#DevoManc